Related Experiment Videos
Fat and the liver--a molecular overview.
Stephen A Harrison1, Anna Mae Diehl
1Brooke Army Medical Center, Ft Sam Houston TX, USA.
Seminars in Gastrointestinal Disease
|April 12, 2002
Summary
Nonalcoholic fatty liver disease (NAFLD) is a chronic liver condition linked to insulin resistance. Understanding its progression to cirrhosis is key for developing targeted treatments.
Area of Science:
- Hepatology
- Metabolic Syndrome
- Oxidative Stress
Background:
- Nonalcoholic fatty liver disease (NAFLD) is a prevalent chronic liver condition in non-drinkers.
- Histological differentiation from alcoholic liver disease is challenging.
- NAFLD is associated with insulin resistance states like obesity, type 2 diabetes mellitus, and dyslipidemia.
Purpose of the Study:
- To elucidate the mechanisms driving the progression of simple steatosis to nonalcoholic steatohepatitis (NASH).
- To identify therapeutic targets for preventing or reversing NASH and halting cirrhosis development.
Main Methods:
- The study focuses on understanding the cellular adaptations to oxidative stress during deranged fatty acid metabolism in insulin resistance.
- Mechanistic insights into the transition from fatty liver to inflammatory liver lesions are explored.
Main Results:
- The transition from simple steatosis to NASH involves complex cellular adaptations.
- Oxidative stress, resulting from impaired fatty acid metabolism in insulin resistance, plays a crucial role.
Conclusions:
- Understanding the mechanisms of NASH development is critical for effective treatment strategies.
- Targeting these mechanisms could prevent or reverse NASH, thereby preventing cirrhosis in NAFLD patients.